Recovery Guide Intervention for Recurrent Psychiatric Hospitalization

June 10, 2009 updated by: Yale University
The purpose of this study is to determine whether Recovery Guide support services are effective in promoting recovery and social integration among psychiatrically disabled individuals who experience high rates of inpatient hospitalizations.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The paradigm shift in mental health treatment from a deficit-and institution- based framework to a recovery and community integration frame necessitates new models of "case management" practices. The Recovery Guide model is just such a model. Beyond theoretical frameworks, the effectiveness of Recovery Guides has not been well studied. It is the intent of this study to conduct a randomized trial examining the effects of Recovery Guides on community tenure and integration. Furthermore, it is the intent of this study to to establish fidelity criteria.

Comparison(s): Recovery Guide services in addition to treatment as usual, compared to treatment as usual.

Study Type

Interventional

Enrollment (Actual)

71

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Connecticut
      • New Haven, Connecticut, United States, 06519
        • Yale-New Haven Psychiatric Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years of age or older
  • Currently admitted in the Yale-New Haven Psychiatric Hospital (YNHPH)
  • A history of two or more prior admissions within the past 18 months
  • Proficient in the use of the English language
  • A DSM-IV diagnosis of Schizophrenia, Schizoaffective Disorder, Psychotic Disorder NOS, or Major Depressive Disorder with Psychotic Features

Exclusion Criteria:

  • Inability to give signed, written consent
  • Primary DSM-IV diagnosis of substance abuse/dependence

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
Recovery Mentor: peer-based supportive care
Behavioral: Recovery Mentor
Provided Recovery Mentor services
No Intervention
No Recovery Mentor, services as usual

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of hospitalizations
Time Frame: 9 months
9 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Sense of community
Time Frame: Baseline, 3 and 9 months
Baseline, 3 and 9 months
Motivation for change
Time Frame: Baseline, 3 and 9 months
Baseline, 3 and 9 months
Social functioning
Time Frame: Baseline, 3 abd 9 months
Baseline, 3 abd 9 months
Hope
Time Frame: Baseline, 3 and 9 months
Baseline, 3 and 9 months
Self-determination
Time Frame: Baseline, 3 and 9 months
Baseline, 3 and 9 months
Functional status
Time Frame: Baseline, 3 and 9 months
Baseline, 3 and 9 months
Treatment relationship
Time Frame: Baseline, 3 and 9 months
Baseline, 3 and 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yale University

Collaborators

Eli Lilly and Company
Connecticut State, Department of Mental Health and Addiction Services

Investigators

  • Principal Investigator: William H Sledge, MD, Yale University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2006

Primary Completion (Actual)

May 1, 2009

Study Completion (Actual)

May 1, 2009

Study Registration Dates

First Submitted

November 15, 2006

First Submitted That Met QC Criteria

November 15, 2006

First Posted (Estimate)

November 16, 2006

Study Record Updates

Last Update Posted (Estimate)

June 12, 2009

Last Update Submitted That Met QC Criteria

June 10, 2009

Last Verified

June 1, 2009

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0607001641

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on Recovery Mentor

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe